SAGA Diagnostics and SensID collaborate on ultra-low allelic frequency control reagents for cancer mutations

15. July 2020Uncategorized

Rostock and Lund, 15 of July 2020 SensID GmbH, headquartered in Rostock, Germany, is a specialist for development and production of reference control materials for clinical genomics. SAGA Diagnostics AB, headquartered in Lund, Sweden, is a cancer genomics company focused on precision oncology and ultrasensitive liquid biopsy monitoring of cancer patients.  Today the two companies announce a … Read More